Nakata B - Search Results

1

[Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].

Tendo M, Nakata B, Nishino H, Inoue M, Kosaka K, Amano R, Yamada N, Hirakawa K. Tendo M, et al. Among authors: nakata b. Gan To Kagaku Ryoho. 2005 Jun;32(6):795-8. Gan To Kagaku Ryoho. 2005. PMID: 15984518 Clinical Trial. Japanese.

2

Various tumor markers for small pancreatic cancer with special reference to the present status of pancreatic cancer in Japan and our experience over the past 2 years.

Satake K, Chung YS, Yokomatsu H, Nakata B, Sawada T, Nishiwaki H, Umeyama K. Satake K, et al. Among authors: nakata b. Pancreas. 1991 Mar;6(2):234-41. doi: 10.1097/00006676-199103000-00017. Pancreas. 1991. PMID: 1886892

3

A clinical evaluation of various tumor markers for the diagnosis of pancreatic cancer.

Satake K, Chung YS, Yokomatsu H, Nakata B, Tanaka H, Sawada T, Nishiwaki H, Umeyama K. Satake K, et al. Among authors: nakata b. Int J Pancreatol. 1990 Aug-Nov;7(1-3):25-36. doi: 10.1007/BF02924217. Int J Pancreatol. 1990. PMID: 2081926 Clinical Trial.

4

[Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].

Nakata B, Onoda N, Chung YS, Maeda K, Nishimura S, Yashiro M, Nitta A, Kubo T, Kato Y, Sowa M. Nakata B, et al. Gan To Kagaku Ryoho. 1995 Jun;22 Suppl 2:176-9. Gan To Kagaku Ryoho. 1995. PMID: 7611785 Japanese.

5

[Establishment of a new scirrhous gastric cancer cell line OCUM-2M from a primary gastric tumor].

Yashiro M, Chung YS, Nishimura S, Yamada N, Sawada T, Kubo T, Nakata B, Sowa M. Yashiro M, et al. Among authors: nakata b. Nihon Shokakibyo Gakkai Zasshi. 1995 Mar;92(3):199-205. Nihon Shokakibyo Gakkai Zasshi. 1995. PMID: 7731088 Japanese.

6

[Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].

Ogawa Y, Chung YS, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sowa M. Ogawa Y, et al. Among authors: nakata b. Gan To Kagaku Ryoho. 1995 Apr;22 Suppl 1:66-70. Gan To Kagaku Ryoho. 1995. PMID: 7747994 Japanese.

7

[Combination therapy of 5-FU and low dose CDDP for advanced and recurrence gastric cancer].

Chung YS, Yamashita Y, Nakata B, Nitta A, Inoue T, Hirayama K, Ogawa M, Kubo T, Kato Y, Shirasaka T, et al. Chung YS, et al. Among authors: nakata b. Gan To Kagaku Ryoho. 1995 Jan;22(1):149-51. Gan To Kagaku Ryoho. 1995. PMID: 7826072 Japanese. No abstract available.

8

[Establishment and characterization of a human breast cancer cell line, OCUB-1].

Sawada T, Chung YS, Nakata B, Kubo T, Kondo Y, Sogabe T, Onoda N, Ogawa Y, Yamada N, Sowa M. Sawada T, et al. Among authors: nakata b. Hum Cell. 1994 Sep;7(3):138-44. Hum Cell. 1994. PMID: 7873497 Japanese.

9

[Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].

Nitta A, Chung YS, Kato Y, Yashiro M, Maeda K, Kubo T, Nakata B, Okuno M, Sowa M. Nitta A, et al. Among authors: nakata b. Gan To Kagaku Ryoho. 1994 Apr;21(5):701-3. Gan To Kagaku Ryoho. 1994. PMID: 8154897 Japanese. No abstract available.

10

Clinical significance of serum CYFRA 21-1 in gastric cancer.

Nakata B, Chung YS, Kato Y, Ogawa M, Ogawa Y, Inui A, Maeda K, Sawada T, Sowa M. Nakata B, et al. Br J Cancer. 1996 Jun;73(12):1529-32. doi: 10.1038/bjc.1996.288. Br J Cancer. 1996. PMID: 8664124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters